6719 abstracts found.



Results filter

A mixed methods study investigating the effects of a home-based exercise programme on functional outcomes and quality of life in patients with breast cancer undergoing (neo) adjuvant chemotherapy.

Year:

Session type:

Theme:

Alison Kelly1
1Queen Margaret University, Edinburgh

PARP inhibition elicits tumour cell-intrinsic immune phenotypes in DNA repair deficient cancers.

Year:

Session type:

Theme:

Roman Chabanon1,Gareth Muirhead2,Dragomir Krastev2,Julien Adam1,Marlène Garrido1,Daphné Morel1,Nicolas Dorvault1,Rebecca Marlow3,Alan Ashworth4,Stephen Pettitt2,Syed Haider2,Andrew Tutt2,Aurélien Marabelle1,Jean-Charles Soria5,Christopher Lord2,Sophie Postel-Vinay1
1Gustave Roussy,2Institute of Cancer Research,3King's College London,4UCSF Helen Diller Family Comprehensive Cancer Centre,5AstraZeneca/MedImmune

ORAI2 promotes tumorigenesis and metastasis in gastric cancer via activation of the PI3K/Akt and FAK/MAPK/ERK pathways

Year:

Session type:

Theme:

Shayi Wu1
1University of Hong Kong

Deciphering the molecular signalling underpinning early-dissemination and metastasis from stage I colorectal cancer

Year:

Session type:

Theme:

Philip Dunne1,Maurice Loughrey2,Helen Coleman2,Aoife McCooey2,Susan Richman3,Andrew Blake4,Keara Redmond2,Dion Morton5,Ian Tomlinson5,Simon Leedham4,Rachael McBride2,Jeffrey Campbell2,Tim Maughan4,Mark Lawler2,S:cort Consortium6
1Centre for Cancer Research & Cell Biology Queen's University Belfast, Belfast, UK ,2Queen's University Belfast, Belfast, UK,3University of Leeds, Leeds, UK,4University of Oxford, Oxford, UK,5University of Birmingham, Birmingham, UK,6S:CORT Consortium, Oxford, UK

New Strategy for the Identification of Squamous Carcinoma Antigens that Induce Therapeutic Immune Responses in Tumor-Bearing Mice

Year:

Session type:

Theme:

Edward Cohen1
1The University of Illinois at Chicago

Ad5NULL-A20 – a precision virotherapy that efficiently and selectively targets αvβ6 positive cancers following intravenous administration

Year:

Session type:

Theme:

Alan Parker1,James Davies1,Gareth Marlow1,Hanni Uusi-Kerttula1,Gillian Seaton1,Luke Piggott1,Richard Clarkson1,John Chester1
1Cardiff University, Cardiff, UK

Evaluation of local follow-up of long-term cancer survivors – The ADAPT Programme

Year:

Session type:

Theme:

Charlotte Summerfield1,Ellie White2,Valerie Goode2,Richard Cowan2,John Radford2
1The University of Manchester,2The Christie NHS Foundation Trust

Infrared imaging to predict oral cancer development in oral epithelial dysplasia

Year:

Session type:

Theme:

Barnaby Ellis1,Conor Whitley1,James Ingham1,Steve Barrett1,Peter Gardner2,Richard Shaw1,Peter Weightman1,Janet Risk1
1University of Liverpool,2University of Manchester

Making 3D possible: large scale organoid expansion using bioprocess design

Year:

Session type:

Theme:

Victoria Marsh Durban1,Mairian Thomas1,Kim Luetchford1,Trevor Dale1,Marianne Ellis1
1Cellesce Ltd

Curcumin as an agent for cancer prevention in colorectal cancer

Year:

Session type:

Theme:

Sam Khan1,Ankur Karmokar1,Zahirah Sidat2,Nalini Foreman1,David Moore3,Anne Thomas1,Karen Brown1
1Leicester Cancer Research Centre, Robert Kilpatrick Clinical Sciences Building, University of Leicester, Leicester,2Hope Clinical Trials Facility, Leicester Royal Infirmary, Leicester,3University College London Hospitals NHS Foundation Trust, London

A biobank analysis of outcomes in patients with malignancy of undefined primary origin

Year:

Session type:

Theme:

Mark Stares1,Rebekah Patton1,Gillian Knowles1,Rachel Haigh1,Colin Barrie1,Lucy Dobbs2,Barry Laird2,Sally Clive1
1NHS Lothian,2Edinburgh University

Development of a medium-throughput colony formation screen for identification of novel radiosensitising drugs for glioblastoma

Year:

Session type:

Theme:

Natividad Gomez-Roman1,Mark R Jackson1,Sandeep Chahal1,Anthony J Chalmers1
1University of Glasgow

Delineating how PIK3CA mutation and PTEN deletion contribute to prostate cancer

Year:

Session type:

Theme:

Manisha Dass1,Helen Pearson1,Matthew Smalley1,Richard Clarkson1,Wayne Phillips2,Jason Li2
1European Cancer Stem Cell Research Insititute, Cardiff University,2Peter MacCallum Cancer Centre, Melbourne

Effect of lipids on IGF axis and subsequent breast cancer risk: observational and causal estimates from independent sources

Year:

Session type:

Theme:

Vanessa Tan1,Caroline Bull1,Nicholas Timpson1
1University of Bristol

Combining tyrosine kinase inhibitors with novel thiosemicarbazone iron chletors in cell lines derived from pediatric solid tumors of neurogenic origin

Year:

Session type:

Theme:

Maria Krchniakova1,Jakub Neradil1,Silvia Chovanova1,Petr Chlapek1,Des. R. Richardson2,Jaroslav Sterba3,Renata Veselska1
1Masaryk University,2University of Sydney,3University Hospital Brno

Developing a digital health intervention to support young adults with cancer: The e-Prehabilitation Study

Year:

Session type:

Theme:

Lisa McCann1,Kathryn McMillan1,Chris Hewitt2
1University of Strathclyde,2NHS Lothi

Developing novel platforms for delivery and investigation of vascular-targeted photodynamic therapy (VTP) of pre-clinical models of cancer; towards multi-modality prostate cancer therapy.

Year:

Session type:

Theme:

Richard Bryant1,Hanna Sjoberg1,Yiannis Philippou1,Iain Tullis1,Danny Allen1,Veerle Kersemans1,Emma Murphy1,Sheena Wallington1,Paul Kinchesh1,Stuart Gilchrist1,Gillies McKenna1,Ian Mills1,Tamar Yechezkel2,Dina Preise2,Lilach Agemy2,Sean Smart1,Boris Vojnovic1,Avigdor Scherz2,Freddie Hamdy1,Ruth Muschel1
1University of Oxford,2The Weizmann Institute of Science

Targeting melanoma’s MCL1 bias unleashes the apoptotic potential of BRAF and ERK1/2 pathway inhibitors

Year:

Session type:

Theme:

Matthew J. Sale1,Emma Minihane1,Noel R. Monks2,Rebecca Gilley1,Frances M. Richards3,Kevin P. Schifferli2,Courtney L. Andersen2,Emma J. Davies2,Mario Aladren Vicente4,Eiko Ozono1,Aleksandra Markovets2,Lisa Drew2,Vikki Flemington2,Theresa Proia2,Duncan I. Jodrell5,Paul D. Smith2,Simon J. Cook1
1Babraham Institute,2AstraZeneca,3Cancer Research UK,4CRUK Therapeutic Discovery Laboratories,5CRUK

Non-Attendance in Two-week wait and Urgent Colorectal Cancer Referrals

Year:

Session type:

Theme:

Vincenza Scanella1,Harpreet Sekhon Inderjit Singh2,Rabiya Aseem2,Jason Smith2,Nikhil Pawa2
1Imperial College London, London, UK,2West Middlesex University Hospital, Isleworth, UK

The landscape of hepatocellular carcinoma in the UK in the past 20 years: the HCCUK/NCRAS partnership.

Year:

Session type:

Theme:

Anya Burton1,Robert Driver2,Vinay Kumar3,Katherine Cullen4,Rhys Pockett4,Deborah Fitzsimmons4,Graeme Alexander5,Tim Cross6,Ian Rowe7,Aileen Marshall8
1Public Health England, London, UK,2University of Leeds, Leeds, UK,3University of Liverpool, Liverpool, UK,4Swansea Centre for Health Economics, Swansea, UK,5University College London, London, UK,6Royal Liverpool and Broadgreen Hospitals, Liverpool, UK,7St James University Hospital Leeds, Leeds, UK,8Royal Free Hospital, London, UK

Statin use and risk of liver cancer: evidence from two population-based studies.

Year:

Session type:

Theme:

Kim Tu Tran1,Úna McMenamin1,Helen Coleman1,Chris Cardwell1,Peter Murchie2,Lisa Iversen2,Amanda Lee2,Aaron Thrift3
1Queen's University Belfast,2University of Aberdeen,3Baylor College of Medicine

CD99 regulation of cancer cell dynamics and tumour formation

Year:

Session type:

Theme:

Adam Odell1,Aarren Mannion2,Alison Taylor3,Pam Jones3,Graham Cook3
1York St. John University,2Karolinska Institute,3University of Leeds

Waiting for a miracle or best medical practice? End-of-life medical ethical dilemmas in Bahrain

Year:

Session type:

Theme:

Barrak Almoosawi1,Sayed Alwadaei1,Hani Humaidan2,Susan Dovey3
1University of Edinburgh,2SMC,3RCSI Bahrain

3-D cell culture models for detection of biomarker indicating anti-EGFR antibody resistance in colon cancer patients

Year:

Session type:

Theme:

Jens Hahne1,Andrea Lampis1,Michele Ghidini2,Margherita Ratti2,Massimiliano Salati1,Chiara Senti2,Rodolfo Passalacqua2,Luciano Cascione3,Chiara Braconi1,Owen Sansom4,Matteo Fassan5,Nicola Valeri1
1The Institute of Cancer Research London,2Istituti Ospitalieri di Cremona,3Institute of Cancer Research Belinzola,4The Beatson Institute for Cancer Research,5University of Padua

Roles of EZH2 and KDM6B during EMT

Year:

Session type:

Theme:

Camille Lachat1,Amandine Etcheverry2,Marc Aubry2,Jean Mosser2,Michael Herfs3,Jean-Paul Feugeas4,Michael Boyer-Guittaut4,Paul Peixoto5,Eric Hervouet5
1INSERM UMR1098,2CHU Rennes, Service de Génétique Moléculaire et Génomique, Rennes F-35033, France ; CNRS, UMR 6290, Institut de Génétique et Développement de Rennes (IGDR), Rennes F-35043, France ; Université Rennes1, UEB, UMS 3480 Biosit, Faculté de Médecine, Rennes F-35043, France ; Plate-forme Génomique Environnementale et Humaine Biosit, Université Rennes1, Rennes F-35043, France,3Laboratory of Experimental Pathology, GIGA-Cancer, University of Liege, Liege, Belgium,4Univ. Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, F-25000 Besançon, France,5Univ. Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, F-25000 Besançon, France ; EPIGENEXP Platform, University of Bourgogne Franche-Comté, F-25000 Besançon, France

Image-based consensus molecular subtype classification (imCMS) of colorectal cancer using deep learning

Year:

Session type:

Theme:

Korsuk Sirinukunwattana1,Enric Domingo1,Susan Richman2,Keara Redmond3,Andrew Blake1,Clare Verrill1,Simon Leedham1,Katerina Chatzipli4,Claire Hardy4,Celina Whalley5,Chieh-Hsi Wu1,Andrew Beggs5,Ultan McDermott6,Philip Dunne3,Angela Meade7,Steven Walker8,Graeme Murray9,Leslie Samuel10,Matt Seymour11,Ian Tomlinson5,Philip Quirke2,Tim Maughan1,Jens Rittscher1,Viktor Koelzer12
1University of Oxford,2University of Leeds,3Queen's University Belfast,4Wellcome Sanger Institute,5University of Birmingham,6AstraZeneca,7University College London,8Almac Group Ltd,9University of Aberdeen,10NHS,11NIHR,12University of Zürich

Safety and efficacy of 12 mg/d lenvatinib (LEN) in patients with unresectable hepatocellular carcinoma (uHCC) and bodyweight >80 kg in REFLECT

Year:

Session type:

Theme:

Arndt Vogel1,Masatoshi Kudo2,Ann-Lii Cheng3,Max W. Sung4,Richard S. Finn5,Albert Y. Lin6,Ghassan K. Abou-Alfa7,Angel Alsina8,Valeriy Breder9,Niall Tebbutt10,Pia Osterlund11,C. J. Yen12,Min Ren13,Soamnauth Misir13,Corina E. Dutcus13,Daniel Palmer14,Philippe Merle15,Matthias Pinter16,TR Jeffry Evans17
1Hannover Medical School,2Kindai University School of Medicine,3National Taiwan University Hospital,4Tisch Cancer Institute at Mount Sinai,5Geffen School of Medicine, UCLA Medical Center,6VA Palo Alto Health Care System,7Memorial Sloan Kettering Cancer Center,8Tampa General Hospital,9N.N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation,10Olivia Newton-John Cancer Centre,11Tampere University and Central Hospital,12National Cheng Kung University Hospital,13Eisai Inc.,14University of Liverpool, Liverpool,15CHU de Lyon -Hospital La Croix-Rousse,16Medical University of Vienna,17University of Glasgow

Patient Perspective of Experimental Cancer Medicine (PpExCaM Survey) – a Patient-led Initiative to Understand the Views of Participating in Early-Phase Trials

Year:

Session type:

Theme:

Mekala Gunaratnam1,Emma Hainsworth1,Terry Emmery2,Tim Meyer1
1University College London Cancer Institute, London, UK,2Patient participant

RAMPART Renal Adjuvant MultiPle Arm Randomised Trial

Year:

Session type:

Theme:

James Larkin1,Angela Meade2,Tom Powles3,Grant Stewart4,Bhavna Oza2,Laurence Albiges5,Axel Bex6,Hanna Bryant2,Toni Choueiri7,Ian Davis8,Tim Eisen9,Alison Fielding10,Elena Frangou2,Patrick Hanlon10,David Harrison11,Rick Kaplan2,Salena Mulhere10,Paul Nathan12,Brian Rini13,Alastair Ritchie2,Clare Shakeshaft2,Ben Smith2,Martin Stockler14,Max Parmar15
1Royal Marsden Hospital,2MRC CTU at UCL,3St Bartholomew’s Hospital,4University of Cambridge,5Institut Gustave Roussy,6Royal Free Hospital,7Dana-Farber Cancer Institute,8Monash University Eastern Health Clinical School and ANZUP Cancer Trials Group,9AstraZeneca and University of Cambridge,10Patient representative,11University of St Andrews,12Mount Vernon Cancer Centre,13Cleveland Clinic,14University of Sydney,15MCR CTU at UCL

Cell culture under perfusion conditions reduces cellular metabolic stress and mimics the in vivo physiological environment in pancreatic cancer

Year:

Session type:

Theme:

Daniel Hughes1,Frances Willenbrock2,Zahir Soonawalla3,Srikanth Reddy3,Michael Silva3,Somnath Mukherjee3,Eric O'Neill2
1University of Oxford, Oxford, UK,2Department of Oncology, University of Oxford, Oxford, UK,3Oxford University Hospitals, Oxford, UK

Participant views of taking part in a tailored cancer awareness intervention: Preliminary participant interview findings from the Awareness and Beliefs About Cancer Trial (ABACus3)

Year:

Session type:

Theme:

Harriet Quinn-Scoggins1,Yvonne Moriarty2,Fiona Wood1,Julia Townson2,Kate Brain1
1Division of Population Medicine, School of Medicine, Cardiff University,2Centre for Trials Research, Cardiff University

Co-design of a remote monitoring application for the first month following colorectal cancer surgery

Year:

Session type:

Theme:

Morven Miller1,John Connaghan1,Lisa McCann1,Hester Van-Wyk2,Campbell Roxburgh2,Roma Maguire1
1University of Strathclyde,2University of Glasgow

A multiplex proteomics analysis reveals a novel plasma biomarker signature that predicts for outcomes in gastro-oesophageal cancer

Year:

Session type:

Theme:

Eilidh McCulloch1,Alan Bilsland1,Liz-Anne Lewsley2,Antonia MacMillan2,Martin MacLeod2,Jennifer Walker1,Jamie Stobo2,James Paul2,W. Nicol Keith1,Patricia Roxburgh1,Fiona Thomson1,T.R. Jeffry Evans1
1Glasgow ECMC, Institute of Cancer Science, University of Glasgow,2CRUK Clinical Trials Unit, Institute of Cancer Science, University of Glasgow

Best Supportive Care in cancer: working models require both resource and accountability for delivery if patients are to benefit.

Year:

Session type:

Theme:

Joanna Bowden1,Mhairi Gilmour2,Steinunn Boyce2,Jane Wilson2
1NHS Fife, Kirkcaldy, UK, University of Edinburgh, Edinburgh, UK, University of St Andrews, St Andrews, UK,2NHS Fife

EXPERIENCE WITH CDK4/6 INHIBITORS: A SINGLE INSTITUTION STUDY

Year:

Session type:

Theme:

Sarah Saeed Qureshi1,Muhammad Farooq Latif1,Syed Hammad Tirmazy1
1Dubai Hospital

Impact of body fatness and metabolic traits on colorectal cancer

Year:

Session type:

Theme:

Emma Vincent1,Caroline Bull1,Joshua Bell1,Neil Murphy1,Nicholas Timpson1,Marc Gunter2
1University of Bristol,2International Agency of Research on Cancer

Incidence and management of 3 years of immune mediated toxicities in metastatic non-small cell lung carcinoma (NSCLC) patients treated with anti PD-1/PD-L1 immunotherapy

Year:

Session type:

Theme:

Grace Tze-en Ding1,Colin Barrie1,Alan Simms2,Melanie Mackean3
1Edinburgh Cancer Centre,2Department of Radiology, NHS Lothian,3Edinburgh

Does testosterone mediate the relationship between vitamin D and prostate cancer?

Year:

Session type:

Theme:

Luke Robles1,Sean Harrison1,Vanessa Tan1,Rhona Beynon1,Alexandra McAleenan1,Karen Dawe1,Tom Gaunt1,Julian Higgins1,Richard Martin1,Sarah Lewis1
1University of Bristol

Novel mechanisms of overcoming apoptotic resistance in Pancreatic Cancer

Year:

Session type:

Theme:

Julie Nicoll1,Daniel Longley1,Chris Scott1
1CCRCB, Queen's University Belfast

Genomic Profiling of Saudi patients with Colorectal Cancer using Next Generation Sequencing

Year:

Session type:

Theme:

Saleh Alghamdi1,Alhanouf Alomani2,Bader Almuzaini2,Abdullah Alsharm1,Fida Aljaser3
1KFMC,2KAIMRC,3KSU

Patients’ experience of nutritional care during cancer treatment

Year:

Session type:

Theme:

Lesley Turner1,Arabella Hayter1,Fiona Davey1,Stephen Wootton2
1NIHR Cancer and Nutrition Collaboration, London, UK,2University of Southampton, Southampton, UK

Socio-demographic variation in routes to diagnosis in head and neck cancer: a population-based analysis

Year:

Session type:

Theme:

Jennifer Deane1,Joanne Patterson1,Linda Sharp1
1Newcastle University

TOPARP-B: A Phase II Randomised Trial of the Poly(ADP)-Ribose Polymerase (PARP) Inhibitor Olaparib for Metastatic Castration Resistant Prostate Cancers (mCRPC) with DNA Damage Repair (DDR) Alterations

Year:

Session type:

Theme:

Joaquin Mateo1,Nuria Porta2,Ursula McGovern3,Tony Elliott4,Robert Jones5,Isabel Syndikus6,Christy Ralph7,Suneil Jain8,Mohini Varughese9,Omi Parikh10,Simon Crabb11,Angus Robinson12,Duncan McLaren13,Alison Birtle14,Jacob Tanguay15,Susana Miranda2,George Seed2,Claudia Bertan2,Aude Espinasse2,Peter Chatfield2,Diletta Bianchini16,Emma Hall2,Suzanne Carreira2,Johann De Bono17
1Vall d’Hebron Institute of Oncology, Barcelona, Spain,2The Institute of Cancer Research, London, UK,3University College Hospital, London, UK,4The Christie Hospital, Manchester, UK,5The Beatson West of Scotland Cancer Centre, Glasgow,6The Clatterbridge Cancer Centre, Birkenhead, UK,7St James's University Hospital, Leeds, UK,8Belfast City Hospital, Belfast, UK,9Musgrove Park Hospital, Taunton, UK,10Royal Blackburn Hospital, Blackburn, UK,11Southampton General Hospital, Southampton, UK,12Royal Sussex County Hospital, Brighton, UK,13Western General Hospital, Edinburgh, UK,14Royal Lancaster Infirmary, Lancaster, UK,15Velindre Cancer Centre, Cardiff, UK,16The Royal Marsden NHS Foundation Trust, UK,17The Institute of Cancer Research, London, UK, London & The Royal Marsden NHS Foundation Trust, London, UK

Anti-oestrogen medication use in breast cancer patients and subsequent risk of gastrointestinal cancers: a two country pooled analysis

Year:

Session type:

Theme:

Úna McMenamin1,Harlinde De Schutter2,Michael B Cook3,Stuart McIntosh4,Brian T Johnston5,Chris Cardwell1
1Queen's University Belfast, Belfast, UK,2Belgian Cancer Registry, Saint-Josse-ten-Noode, Belgium,3National Cancer Institute, Bethesda, US,4Belfast Health & Social Care Trust, Belfast, UK,5Belfast Health & Social Care Trust

Genome-wide association study of acute toxicity and quality of life in breast cancer patients treated by surgery and radiotherapy in the REQUITE cohort study

Year:

Session type:

Theme:

Tim Rattay1,Colin Veal1,David Azria2,Jenny Chang-Claude3,Susan Davidson4,Alison M Dunning5,Dirk de Ruysscher6,Sara Gutierrez-Enriquez7,Philippe Lambin8,Anusha Müller3,Tiziana Rancati9,Barry S Rosenstein10,Petra Seibold3,Elena Sperk11,R Paul Symonds1,Riccardo Valdagni9,Ana Vega12,Liv Veldeman13,Adam Webb1,Catharine West14,Christopher J Talbot1,On behalf of the15
1University of Leicester, Leicester, UK,2 Institut du Cancer Montpellier (ICM), Montpellier, France,3German Cancer Research Center (DKFZ), Heidelberg, Germany,4The Christie Hospital NHS Foundation Trust, Manchester, UK,5University of Cambridge, Cambridge, UK,6University Hospitals Leuven, KU Leuven, Leuven, Belgium,7Vall d’Hebron Institute of Oncology, Barcelona, Spain,8MAASTRO Clinic, Maastricht, Netherlands,9 Istituto di Ricovero e Cura a Carattere Scientifico, Fondazione Istituto Nazionale dei Tumori Milan, Milan, Italy,10Icahn School of Medicine at Mount Sinai, New York, US,11University Medical Centre Mannheim, Heidelberg, Germany,12Fundacion Publica Galega Medicina Xenomica, A Coruña, Spain,13Universiteit Ghent, Ghent, Belgium,14University of Manchester, Manchester, UK,15REQUITE Study, Leicester, UK

Addressing the variation in adjuvant chemotherapy treatment for colorectal cancer (CRC): can a regional intervention promote national change?

Year:

Session type:

Theme:

Daniel Swinson1,John C. Taylor2,Jenny F. Seligmann3,Rebecca Birch4,Alice Dewdney5,Hannah Rossington4,Victoria A. Brown6,Jo Dent7,Philip Quirke8,Eva J. A. Morris4
1St James's University Hospital, Leeds, UK,2Leeds Institute of Data Analytics, University of Leeds, Leeds, UK,3St James's University Hospital, Leeds, UK, Leeds Teaching Hospitals Trust, Leeds, Leeds, UK,4Cancer Epidemiology Group, Leeds, UK, Section of Epidemiology and Biostatistics, Leeds, UK, Leeds Institute of Cancer & Pathology, Leeds, UK, Leeds Institute for Data Analytics, University of Leeds, Leeds, UK,5Department of Radiotherapy, Weston Park Hospital, Sheffield, UK, Sheffield Teaching Hospitals, Sheffield, UK,6Queen’s Centre for Oncology and Haematology, Hull, UK, Hull University Hospitals NHS Trust, Hull, UK,7Department of Oncology, Huddersfield Royal Infirmary, Calderdale and Huddersfield NHS Foundation Trust, Huddersfield, UK,8Section of Pathology and Tumour Biology, Leeds, UK, Leeds Institute of Cancer & Pathology, Leeds, UK, University of Leeds, Leeds, UK

Engineered 3D-microtumours for personalized cancer therapy

Year:

Session type:

Theme:

Nobina Mukherjee1,Prof. Hagan Bayley1
1University of Oxford

ADSCaN: A Randomised Phase II study of Accelerated, Dose escalated, Sequential Chemo-radiotherapy in Non-Small Cell Lung Cancer (NSCLC)

Year:

Session type:

Theme:

Claire Lawless1,Kathleen Boyd2,Corinne Faivre-Finn3,John Fenwick4,Tom Haswell5,David Landau6,Jason Lester7,Joe Maguire8,Elaine McCartney1,Jim Paul1,Matthew Hatton9

1CRUK Clinical Trials Unit, Beatson West of Scotland Cancer Centre, Glasgow, UK,2Health Economics & Health Technology Assessment, University of Glasgow, Glasgow, UK,3The Christie NHS Foundation Trust, Manchester, UK,4Gray Institute of Radiation Oncology & Biology, University of Oxford, Oxford, UK,5West of Scotland Cancer Research Consumer Panel, Glasgow, UK,6Guys & St Thomas NHS Trust, London, UK,7Velindre Cancer Centre, Cardiff, UK,8Clatterbridge Cancer Centre, Liverpool, UK,9Weston Park Hospital, Sheffield, UK


Palliative radiotherapy to the oesophagus: Less is just as good.

Year:

Session type:

Theme:

Shefali Parikh1,Oliver Coen1,Rebecca Goody1,Ganesh Radhakrishna2,Paul Hatfield1,Mohan Hingorani1
1Leeds Cancer Centre,2The Christie, Manchester

Predictive risk factors of venousthromboembolism (VTE) associated withperipherally inserted central catheters(PICC) in ambulant solid cancer patients:retrospective single Centre cohort study

Year:

Session type:

Theme:

Osamah al-asadi1
1nhs